Related Experiment Videos
Cardiac arrest after oxymetazoline nasal spray
1Department of Anesthesiology, University of South Florida College of Medicine, Tampa 33612-4799, USA.
Journal of Clinical Anesthesia
|September 1, 1995
Summary
Oxymetazoline nasal spray can cause severe hypertension and bradycardia in young children, even at low doses. Careful dosing and anticholinergic pretreatment are recommended for pediatric nasal endoscopy.
Area of Science:
- Anesthesiology
- Pharmacology
- Pediatrics
Background:
- Oxymetazoline is an alpha-1 adrenergic agonist used for nasal vasoconstriction.
- Its use in pediatric patients undergoing general anesthesia requires careful consideration of potential cardiovascular effects.
Observation:
- A 2-year-old patient received 0.025% oxymetazoline during nasal endoscopy.
- The patient developed severe hypertension with reflex bradycardia, progressing to sinus arrest.
Findings:
- The incident highlights a severe adverse reaction to a standard dose of oxymetazoline in a pediatric patient.
- Successful resuscitation was achieved with atropine and cardiopulmonary support.
Implications:
- Lowering the oxymetazoline dose may mitigate risks in pediatric anesthesia.
- Pretreatment with anticholinergic agents could prevent severe cardiovascular events.
- This case underscores the need for vigilant cardiovascular monitoring during oxymetazoline administration in children.